GB Sciences Current Valuation vs. Net Income
| GBLX Stock | USD 0.0003 0.0002 40.00% |
For GB Sciences profitability analysis, we use financial ratios and fundamental drivers that measure the ability of GB Sciences to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well GB Sciences utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between GB Sciences's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of GB Sciences over time as well as its relative position and ranking within its peers.
GBLX |
GB Sciences Net Income vs. Current Valuation Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining GB Sciences's current stock value. Our valuation model uses many indicators to compare GB Sciences value to that of its competitors to determine the firm's financial worth. GB Sciences is rated # 3 in current valuation category among its peers. It is one of the top stocks in net income category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value GB Sciences by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for GB Sciences' Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.GBLX Current Valuation vs. Competition
GB Sciences is rated # 3 in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Biotechnology industry is currently estimated at about 402.26 Million. GB Sciences holds roughly 10.19 Million in current valuation claiming about 2.53% of stocks in Biotechnology industry.
GBLX Net Income vs. Current Valuation
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
GB Sciences |
| = | 10.19 M |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
GB Sciences |
| = | (530.87 K) |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
GBLX Net Income Comparison
GB Sciences is currently under evaluation in net income category among its peers.
GB Sciences Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in GB Sciences, profitability is also one of the essential criteria for including it into their portfolios because, without profit, GB Sciences will eventually generate negative long term returns. The profitability progress is the general direction of GB Sciences' change in net profit over the period of time. It can combine multiple indicators of GB Sciences, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
GB Sciences, Inc. engages in the research and development of plant-based medicines in North America and Europe. GB Sciences, Inc. was incorporated in 2001 and is based in Las Vegas, Nevada. Growblox Sciences operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 3 people.
GBLX Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on GB Sciences. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of GB Sciences position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the GB Sciences' important profitability drivers and their relationship over time.
Learn to be your own money manager
Our tools can tell you how much better you can do entering a position in GB Sciences without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Sign In To Macroaxis Now
Sign In To MacroaxisSign in to explore Macroaxis' wealth optimization platform and fintech modules |
| All Next | Launch Module |
Use Investing Themes to Complement your GB Sciences position
In addition to having GB Sciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Recycling Thematic Idea Now
Recycling
West management companies as well as entities specializing in pollution control and recycling. The Recycling theme has 45 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Recycling Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for GBLX Pink Sheet Analysis
When running GB Sciences' price analysis, check to measure GB Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GB Sciences is operating at the current time. Most of GB Sciences' value examination focuses on studying past and present price action to predict the probability of GB Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GB Sciences' price. Additionally, you may evaluate how the addition of GB Sciences to your portfolios can decrease your overall portfolio volatility.